Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 2Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Leukemia 42Lymphoma 33Melanoma 32Breast Neoplasms 31Leukemia, Myeloid, Acute 28Precursor Cell Lymphoblastic Leukemia-Lymphoma 23Leukemia, Lymphocytic, Chronic, B-Cell 23Lymphoma, Non-Hodgkin 22Multiple Myeloma 21Lymphoma, Follicular 21Myelodysplastic Syndromes 19Prostatic Neoplasms 18Neuroblastoma 18Lymphoma, Mantle-Cell 17Lymphoma, Large B-Cell, Diffuse 17Leukemia, Myeloid, Chronic-Phase 16Hodgkin Disease 15Neoplasms, Plasma Cell 14Lymphoma, Large-Cell, Immunoblastic 14Ovarian Neoplasms 13Lung Neoplasms 13Congenital Abnormalities 13Lymphoma, B-Cell, Marginal Zone 12Leukemia, Myeloid, Accelerated Phase 12Carcinoma, Non-Small-Cell Lung 12Burkitt Lymphoma 12Leukemia, Myelogenous, Chronic, BCR-ABL Positive 11Glioblastoma 11Carcinoma, Ovarian Epithelial 11Colorectal Neoplasms 10

Interventions

Dexamethasone 27Melphalan 22Cyclophosphamide 15Peripheral Blood Stem Cell Transplantation 14Filgrastim 13Bortezomib 12Calcium Dobesilate 9Lenalidomide 7fludarabine phosphate 6Whole-Body Irradiation 5Mycophenolic Acid 5Cyclosporine 5Thalidomide 4Interferon-alpha 4Etoposide 4Busulfan 4miridesap 3dexamethasone acetate 3Radiotherapy 3Epoetin Alfa 3Doxycycline 3Darbepoetin alfa 3Carboplatin 3pomalidomide 2liposomal amphotericin B 2ixazomib 2daratumumab 2birtamimab 2Thiotepa 2Tacrolimus 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Immunoglobulin Light-chain Amyloidosis × sargramostim × Clear all
NCT00007995 2013-02-04

Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients Who Have Multiple Myeloma or Primary Systemic Amyloidosis

National Cancer Institute (NCI)

Phase 2 Completed
75 enrolled
Plasma cell

Immunoglobulin Light-chain Amyloidosis, Multiple Myeloma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡